Evaluation of Platelet Gel Characteristics Using Thrombin Produced by the Thrombin Processing Device: A Comparative Study

Journal of Oral and Maxillofacial Surgery

Volumn 66, Issue 4, 2008, Pages 632-638

  Semple, Elisabeth ^a   Speck, Edwin R ^a   Aslam, Rukhsana ^a   Kim, Michael ^b   Kumar, Vijay ^c   Semple, John W ^b  

^a CANADIAN BLOOD SERVICES   (Canada)

^b ST MICHAEL'S HOSPITAL   (Canada)

^c Thermogenesis Corp   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALCOHOL; PLATELET DERIVED GROWTH FACTOR BETA RECEPTOR; THROMBIN; TRANSFORMING GROWTH FACTOR BETA;

ARTICLE; CELL CULTURE; CELL PROLIFERATION; CELL VIABILITY; CONTROLLED STUDY; FLOW CYTOMETRY; HUMAN; HUMAN CELL; THROMBOCYTE RICH PLASMA;

ANIMALS; CATTLE; CELL PROLIFERATION; CELL SURVIVAL; CELLS, CULTURED; ETHANOL; FIBROBLASTS; GELS; HUMANS; MACROPHAGES; PLATELET ACTIVATION; PLATELET-RICH PLASMA; PROTO-ONCOGENE PROTEINS C-SIS; THROMBIN; TRANSFORMING GROWTH FACTOR BETA;

EID: 40849088209     PISSN: 02782391     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.joms.2007.06.623     Document Type: Article

References (36)

1. Knighton D., Ciresi K., Fiegel V., et al. Classification and treatment of chronic nonhealing wounds. Successful treatment with autologous platelet-derived wound healing factors (PDWHF). Ann Surg 204 (1986) 322
2. Steed D.L., Goslen J.B., Holloway G.A., et al. Randomized prospective double-blind trial in healing chronic diabetic foot ulcers. CT-102 activated platelet supernatant, topical versus placebo. Diabetes Care 15 (1992) 1598
3. Stacey M.C., Mata S.D., Trengove N.J., et al. Randomised double-blind placebo controlled trial of topical autologous platelet lysate in venous ulcer healing. Eur J Vasc Endovasc Surg 20 (2000) 296
4. Margolis D.J., Kantor J., Santanna J., et al. Effectiveness of platelet releasate for the treatment of diabetic neuropathic foot ulcers. Diabetes Care 24 (2001) 483
5. Fennis J.P., Stoelinga P.J., and Jansen J.A. Mandibular reconstruction: A clinical and radiographic animal study on the use of autogenous scaffolds and platelet-rich plasma. Int J Oral Maxillofac Surg 31 (2002) 281
6. Bhanot S., and Alex J.C. Current applications of platelet gels in facial plastic surgery. Facial Plast Surg 18 (2002) 27
7. Senet P., Bon F.X., Benbunan M., et al. Randomized trial and local biological effect of autologous platelets used as adjuvant therapy for chronic venous leg ulcers. J Vasc Surg 38 (2003) 1342
8. Choi B.H., Im C.J., Huh J.Y., et al. Effect of platelet-rich plasma on bone regeneration in autogenous bone graft. Int J Oral Maxillofac Surg 33 (2004) 56
9. Giannini G., Mauro V., Agostino T., et al. Use of autologous fibrin-platelet glue and bone fragments in maxillofacial surgery. Transfus Apher Sci 30 (2004) 139
10. Anitua E., Andia I., Ardanza B., et al. Autologous platelets as a source of proteins for healing and tissue regeneration. Thromb Haemost 91 (2004) 4
11. Slater M., Patava J., Kingham K., et al. Involvement of platelets in stimulating osteogenic activity. J Orthop Res 13 (1995) 655
12. Marx R.E., Carlson E.R., Eichstaedt R.M., et al. Platelet-rich plasma: Growth factor enhancement for bone grafts. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 85 (1998) 638
13. Steen V.M., and Holmsen H. Current aspects on human platelet activation and responses. Eur J Haematol 38 (1987) 383
14. Ledent E., Wasteson A., and Berlin G. Growth factor release during preparation and storage of platelet concentrates. Vox Sang 68 (1995) 205
15. Eppley B.L., Woodell J.E., and Higgins J. Platelet quantification and growth factor analysis from platelet-rich plasma: Implications for wound healing. Plast Reconstr Surg 114 (2004) 1502
16. Tsay R.C., Vo J., Burke A., et al. Differential growth factor retention by platelet-rich plasma composites. J Oral Maxillofac Surg 63 (2005) 521
17. Kajitani M., Ozdemir A., Aguinaga M., et al. Severe hemorrhagic complication due to acquired factor V inhibitor after single exposure to bovine thrombin product. J Card Surg 15 (2000) 378
18. Ortel T.L., Mercer M.C., Thames E.H., et al. Immunological impact and clinical outcomes after surgical exposure to bovine thrombin. Ann Surg 233 (2001) 88
19. Beghi E., Gandolfo C., Ferrarese C., et al. Bovine spongiform encephalopathy and Creutzfeldt-Jacob disease: Fact and uncertainties underlying the causal link between animal and human disease. Neurol Sci 25 (2004) 122
20. Butenas S., and Mann K.G. Blood coagulation. Biochemistry (Mosc) 67 (2002) 3
21. Kumar V., Madsen T., Zhu H., et al. Stability of human thrombin produced from 11 ml of plasma using the thrombin processing device. J Extra Corpor Technol 39 (2007) 18
22. Clauss A. Gerinnungsphysiologische schnellmethode zur bestimmung des fibrinogens. Acta Haematol 17 (1957) 237
23. Sayeh E., Sterling K., Speck E., et al. IgG antiplatelet immunity is dependent on an early innate natural killer cell-derived interferon-gamma response that is regulated by CD8+ T cells. Blood 103 (2004) 2705
24. Nguyen A., Gemmell C.H., Yeo E.L., et al. Ethanol inhibits thrombin-induced secretion of the contents of human platelet dense and alpha-granules and lysosomes. Thromb Haemost 80 (1998) 662
25. Rubin R. Effect of ethanol on platelet function. Alcohol Clin Exp Res 23 (1999) 1114
26. Bryckaert M., Rendu F., Tobelem G., et al. PDGF modifies phosphoinositide metabolism and inhibits aggregation and release in human platelets. Biochem Biophys Res Commun 135 (1986) 52
27. Bryckaert M., Rendu F., Tobelem G., et al. Collagen-induced binding to human platelets of platelet-derived growth factor leading to inhibition of P43 and P20 phosphorylation. J Biol Chem 264 (1989) 4436
28. Taylor J.J., and Woolsey R.M. Dilute ethyl alcohol: Effect on the sciatic nerve of the mouse. Arch Phys Med Rehabil 57 (1976) 233
29. Stephens P., al-Khateeb T., Davies K., et al. An investigation of the interaction between alcohol and fibroblasts in wound healing. Int J Oral Maxillofac Surg 25 (1996) 161
30. Tapani E., Taavitsainen M., Lindros K., et al. Toxicity of ethanol in low concentrations. Experimental evaluation in cell culture. Acta Radiol 37 (1996) 923
31. Luo J., and Miller M.W. Differential sensitivity of human neuroblastoma cell lines to ethanol: Correlations with their proliferative responses to mitogenic growth factors and expression of growth factor receptors. Alcohol Clin Exp Res 21 (1997) 1186
32. Kim T.I., Tchah H., Cho E.H., et al. Evaluation for safety of cultured corneal fibroblasts with cotreatment of alcohol and mitomycin C. Invest Ophthalmol Vis Sci 45 (2004) 86
33. De Somer F., De Brauwer V., Vandekerckhove M., et al. Can autologous thrombin with a rest fraction of ethanol be used safely for activation of concentrated autologous platelets applied on nerves?. Eur Spine J 15 (2006) 501
34. Ross R., Raines E.W., and Bowen-Pope D.F. The biology of platelet-derived growth factor. Cell 46 (1986) 155
35. Bombara C., and Ignotz R. TGF-beta inhibits proliferation of and promotes differentiation of human promonocytic leukemia cells. J Cell Physiol 153 (1992) 30
36. Semple E., Madsen T., and Semple J. Quality of thrombin produced from the patient's own plasma using the TPDT, a new thrombin processing device. J Extra Corpor Technol 37 (2005) 196